Roche Products Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
211 result(s) found, displaying 71 to 80
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Risdiplam
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Satralizumab
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for POLIVY polatuzumab vedotin 140 mg powder for injection vial.
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
-
-
Prescription medicine registrationActive ingredients: baloxavir marboxil.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TECENTRIQ atezolizumab (rch) 840 mg/14 mL injection concentrated vial.
-
Prescription medicine registrationActive ingredients: pertuzumab; trastuzumab.